New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 26, 2014
10:45 EDTMNKD, MNKDSummer Street's chief scientific officer holds analyst/industry conference call
Chief Scientific Officer Classen discusses Mannkind's inhaled insulin and whether it is approvable on an Analyst/Industry conference call to be held on March 26 at 11 am.
News For MNKD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 29, 2014
19:32 EDTMNKDMannKind confirms receipt of $150M licensing upfront payment
Subscribe for More Information
September 24, 2014
17:01 EDTMNKDMannKind announces closing of global licensing agreement with Sanofi
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use